Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

August 20, 2023

Study Completion Date

August 20, 2023

Conditions
HepatomaPancreas Cancer
Interventions
PROCEDURE

Thoracic continuous epidural analgesia

"Continuous epidural catheter (Portex ™, Epidural Minipack , Smiths Medical), infused with 0.0625% bupivacaine (Marcaine™, Aspen Holdings) with morphine (morphine M\&H™) 0.02 mg/ml 5 ml/h postoperative until POD3 morning Connected with The Sapphire ™ Infusion System Patient-Controlled-Analgesia (PCA) pump(fentanyl (fentanyl-Hameln™, Siam Bioscience): intravenous bolus mode only 15 ug/bolus, lockout interval 5 minutes, 4-hour limit 200 ug)~Postoprative analgesia: intravenous paracetamol (infulgan ™, Yuria-Pharm), tablet paracetamol (SaRa ™), Parecoxib (Dynastat ™, Pfizer), Etoricoxib (Arcoxia ™, MSD)"

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT04920019 - Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery | Biotech Hunter | Biotech Hunter